1. GPCR/G Protein Neuronal Signaling
  2. Adrenergic Receptor
  3. MDL-19744A

MDL-19744A is an orally active and selective α1-adrenergic receptor antagonist, with rat α1-adrenergic receptor IC50 of 8 nM. MDL-19744A increases renal blood flow, dose-related decreases mean arterial blood pressure, increases urinary sodium excretion, and mediates renal vasodilation. MDL-19744A can be used for the research of hypertension.

For research use only. We do not sell to patients.

MDL-19744A

MDL-19744A Chemical Structure

CAS No. : 97233-26-6

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Adrenergic Receptor Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

MDL-19744A is an orally active and selective α1-adrenergic receptor antagonist, with rat α1-adrenergic receptor IC50 of 8 nM. MDL-19744A increases renal blood flow, dose-related decreases mean arterial blood pressure, increases urinary sodium excretion, and mediates renal vasodilation. MDL-19744A can be used for the research of hypertension[1].

IC50 & Target[1]

α1-adrenergic receptor

 

In Vitro

MDL-19744A (Compound 1) potently and selectively inhibits α1-adrenergic receptor binding in rat cerebrocortex tissue, with an IC50 of 8 nM for α1 receptors[1].
MDL-19744A (30 min) potently antagonizes α1-adrenergic receptor-mediated vasoconstriction in isolated rabbit aortic strips, with a pA2 of 8.13[1].
MDL-19744A (3 μM) is inactive as a β-adrenergic receptor blocker in isolated guinea pig ventricles[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

MDL-19744A (Compound 1) (30 mg/kg; p.o.; single dose) produces a maximal mean arterial blood pressure reduction of -70 mmHg in conscious spontaneously hypertensive rats[1].
MDL-19744A (0.03-3 mg/kg; i.v.; single dose) produces decreases in mean arterial blood pressure in anesthetized normotensive dogs, with an ED15 for hypotension of 0.08 mg/kg and a maximal mean arterial blood pressure reduction of -47 mmHg at 1 mg/kg i.v[1].
MDL-19744A (0.01-1 mg/kg; i.v.; cumulative dose) produces dose-dependent increases in renal blood flow and increases in urinary sodium excretion in anesthetized normotensive dogs[1].

MDL-19744A (0.1-3 mg/kg; i.v.; single dose) selectively antagonizes α1-adrenergic receptors in pithed rats, shifting Phenylephrine (HY-B0769)-induced pressor responses at 0.1-1.0 mg/kg i.v. while only weakly affecting α2-mediated responses at 3.0 mg/kg i.v[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: spontaneously hypertensive rats (SHR) (conscious)[1]
Dosage: 30 mg/kg
Administration: p.o.; single dose
Result: Produced a maximal decrease in mean arterial blood pressure of -70 mmHg.
Animal Model: normotensive dogs (anesthetized)[1]
Dosage: 0.01 mg/kg; 0.03 mg/kg; 0.1 mg/kg; 0.3 mg/kg; 1.0 mg/kg
Administration: i.v.; cumulative dose
Result: Produced a 9% increase in renal blood flow and a -5% change in mean arterial blood pressure at 0.01 mg/kg cumulative dose.
Produced a 17% increase in renal blood flow and a -9% change in mean arterial blood pressure at 0.03 mg/kg cumulative dose.
Produced a 27% increase in renal blood flow and a -15% change in mean arterial blood pressure at 0.1 mg/kg cumulative dose.
Produced a 34% increase in renal blood flow, a -23% change in mean arterial blood pressure, and increased urinary sodium excretion from a baseline of 42 to 104 µequiv/min at 0.3 mg/kg cumulative dose.
Produced a 42% increase in renal blood flow and a -32% change in mean arterial blood pressure at 1.0 mg/kg cumulative dose.
Animal Model: rats[1]
Dosage: 0.1 mg/kg; 0.3 mg/kg; 1.0 mg/kg; 3 mg/kg
Administration: i.v.; single dose
Result: Shifted the Phenylephrine-induced diastolic blood pressure dose-response curve (DR2 = 0.07, 0.02 mg/kg) at doses of 0.1-1.0 mg/kg.
Weakly affected α2-mediated responses at 3.0 mg/kg i.v.
Molecular Weight

371.49

Formula

C21H25NO3S

CAS No.
SMILES

O=C1C2=C(SC(C)=C2)CC[C@H]1CN[C@@H]3[C@@H]([C@H](CC3)OC4=CC=CC=C4)O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
MDL-19744A
Cat. No.:
HY-183954
Quantity:
MCE Japan Authorized Agent: